A novel stop-gain pathogenic variant in flt4 and a nonsynonymous pathogenic variant in ptpn11 associated with congenital heart defects

HIGHLIGHTS

• who: Avisa Tabib from the The present research was conducted in accordance with the Declaration of HelsinkiEthical approval was obtained from the Ethics Committees of Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran (IR.RHC.REC.1399.017). have published the research: A novel stop-gain pathogenic variant in FLT4 and a nonsynonymous pathogenic variant in PTPN11 associated with congenital heart defects, in the Journal: (JOURNAL)
• what: The authors utilized whole-exome sequencing to determine the genetic causes of CHDs in 3 unrelated pedigrees and succeeded in identifying a novel . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.